Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Kala Pharmaceuticals Inc
KALACurrent price
6.92 USD
+0.12 USD (+1.76%)
Last closed
7.03 USD
Company
www.kalarx.com
ISIN
US4831191030
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
28 167 956 USD
Yield for 12 month
-12.52 %
1Y
3Y
5Y
10Y
15Y
KALA
KALA BIO, Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of innovative therapies for rare and severe eye diseases in the United States. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts. Address: 1167 Massachusetts Avenue, Arlington, MA, United States, 02476
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
15.00 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
+3 892 000 USD
Current Quarter
–
Last Quarter
–
Current Year
-303 000 USD
Last Year
+1 332 000 USD
Current Quarter
–
Last Quarter
-61 000 USD
Key Figures KALA
1 year
3 years
5 years
10 years
EBITDA
-40 978 000 USD
Operating Margin TTM
Price to Earnings
–
Return On Assets TTM
-40.25 %
PEG Ratio
–
Return On Equity TTM
-248.11 %
Wall Street Target Price
15.00 USD
Revenue TTM
–
Book Value
2.72 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-100.00 %
Dividend Yield
–
Gross Profit TTM
1 332 000 USD
Earnings per share
-11.67 USD
Diluted Eps TTM
-11.67 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics KALA
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History KALA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
1:50
Payout Ratio
–
Last Split Date
21.10.2022
Stock Valuation KALA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
0.042
Price Sales TTM
1.16
Enterprise Value EBITDA
-0.16
Price Book MRQ
4.11
Financials KALA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators KALA
For 52 weeks
4.21 USD
9.25 USD
50 Day MA
6.35 USD
Shares Short Prior Month
30 475
200 Day MA
6.54 USD
Short Ratio
1.91
Shares Short
26 310
Short Percent
0.85 %
BeatStart